Patents by Inventor Shahin Fesharaki

Shahin Fesharaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral dosage forms of ibrutinib
    Patent number: 11433072
    Abstract: Stable and bioavailable oral dosage forms of ibrutinib, the dosage forms comprising ibrutinib and an acidifying agent. The dosage forms can further comprise a binder, such as sodium alginate, a surfactant, a lubricant, a filler and/or a disintegrant. Methods of treating cancers, particularly blood cancers, and graft versus host disease comprising administering to a patient in need thereof a dosage form comprising ibrutinib and an acidifying agent.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: September 6, 2022
    Assignee: HIKMA PHARMACEUTICALS USA, INC.
    Inventors: Mahmoud Ghannam, Shahin Fesharaki, Mohammad Al Hreebat, Ahmad Arif Mohammad
  • IMMEDIATE RELEASE ABUSE DETERRENT TABLET
    Publication number: 20200078354
    Abstract: The invention relates to an abuse deterrent immediate release tablet.
    Type: Application
    Filed: November 15, 2019
    Publication date: March 12, 2020
    Applicant: Allergan Sales, LLC
    Inventors: Rahul Sareen, Shahin Fesharaki, Parag Shah
  • IMMEDIATE RELEASE ABUSE DETERRENT TABLET
    Publication number: 20170304297
    Abstract: The invention relates to an abuse deterrent immediate release tablet.
    Type: Application
    Filed: July 3, 2017
    Publication date: October 26, 2017
    Applicant: Allergan Sales, LLC
    Inventors: Rahul Sareen, Shahin Fesharaki, Parag Shah
  • Modified Release Tranexamic Acid Formulation
    Publication number: 20160287541
    Abstract: A modified release dosage form for the oral administration of tranexamic acid.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 6, 2016
    Inventors: Mayank R. Joshi, Shahin Fesharaki
  • Modified release tranexamic acid formulation
    Patent number: 9387178
    Abstract: A modified release dosage form for the oral administration of tranexamic acid.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: July 12, 2016
    Assignee: Actavis, Inc.
    Inventors: Mayank R. Joshi, Shahin Fesharaki
  • Immediate Release Abuse Deterrent Tablet
    Publication number: 20150224097
    Abstract: The invention relates to an abuse deterrent immediate release tablet.
    Type: Application
    Filed: November 22, 2011
    Publication date: August 13, 2015
    Applicant: Watson Pharmaceuticals, Inc.
    Inventors: Rahul Sareen, Shahin Fesharaki, Parag Shah
  • Modified release tranexamic acid formulation
    Patent number: 8597683
    Abstract: A modified release dosage form for the oral administration of tranexamic acid.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: December 3, 2013
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Mayank R. Joshi, Shahin Fesharaki
  • Modified Release Tranexamic Acid Formulation
    Publication number: 20120135079
    Abstract: A modified release dosage form for the oral administration of tranexamic acid.
    Type: Application
    Filed: November 30, 2010
    Publication date: May 31, 2012
    Applicant: WATSON PHARMACEUTICALS, INC.
    Inventors: Mayank R. Joshi, Shahin Fesharaki